ANA MARIA DE JESUS: Open Payments
NPI 1801497706 · LOS ALAMITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 33 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $333 |
| Supernus Pharmaceuticals, Inc. | 2 | $142 |
| ABBVIE INC. | 4 | $76 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| Alkermes, Inc. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Neos Therapeutics, LP | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: REXULTI, Qelbree, VRAYLAR, SPRAVATO, ARISTADA, COBENFY, UZEDY, FANAPT.
Industry payments across CA — which companies pay providers there.
